Introduction
Trypanosoma cruzi is an obligate intracellular parasite, causing a chronic debilitating illness, Chagas' disease, in millions of people in Latin America. It infects most cell types, including fibroblasts, epithelial cells, endothelial cells, myocytes, and macrophages. Trypomastigote, the infective form of T. cruzi, adheres to specific receptors on the outer membrane of host cells as a prelude to intracellular invasion. Adhesion is mediated by at least two parasite ligands that react with carbohydrate receptor epitopes on the host cell surface (Pereira, 1994) . One of the ligands is the trans-sialidase, which promotes attachment by reacting with ~2,3-1inked sialyl epitopes, and the other is penetrin, which reacts with host cell receptors containing heparan sulfate moieties.
Trypomastigote binding to the host cell surface does not, by itself, guarantee access of the parasite into the intracellular environment. In fact, it is possible to prevent adherent parasites from entering culture cells by blocking early metabolic responses that arise during host cell-parasite interactions (Tardieux et al., 1994; Moreno et al., 1994; Yakubu et al., 1994) and by altering lysosome traffic in the mammalian cells (Tardieux et al., 1992) . T. cruzi invasion may therefore require activation of specific signaling pathways critical for parasite entry into host cells. This hypothesis is consistent with current concepts of cellular invasion by virus and bacteria, which can activate surface membrane signaling molecules in their interplay with mammalian cell hosts (Gooding, 1992; Bliska et al., 1993) . As an attempt to find the nature of these signaling pathways, we measured T. cruzi invasion of cell lines activated with various growth factors or genetically resistant to cytokine stimulation. We found that mink lung epithelial cells with a defect in the genes encoding signaling receptors I and II for transforming growth factor 13 (TGFIS) were resistant to TGFI~ (Laiho et al., 1990; Wrana et al., 1992) as well as to T. cruzi invasion. Although T. cruzi could not invade the mutant cells, they attached to them at the same or at higher levels than to parental cells. Transfection of the mutants with plasmids carrying wild-type receptor genes restored response both to TGF~ action and T. cruzi invasion. T. cruzi invasion of other cell lines is also consistent with a requirement for TGFJ3 signaling. This signaling pathway may be activated by a factor secreted by infective trypomastigotes, as suggested by the results with a TGFI3-responsive reporter gene.
TGFI3 induces signals in mammalian cells that lead to many types of biological activities, including regulation of cell proliferation and differentiation, extracellular matrix deposition, and modulation of many inflammatory and immune responses (Roberts and Sporn, 1990; Massagu~, 1990; Miyazono et al., 1994) . It is now apparent that TGFI3 signaling in nonphagocytic cells is subverted by a microbial invader to gain access into a privileged niche, the host cell cytoplasm.
Results

Epithelial Cell Mutants Lacking TGFI~ Receptor I or II Are Nonpermissive to T. cruzi Infection
Mink lung epithelial cells resistant to TGFI3 action were originally isolated by chemical mutagenesis. One mutant phenotype, class R, expresses receptor II but not receptor I, while another phenotype, class DR, expresses receptor I but not receptor II (Laiho et al., 1990; Wrana et al., 1992) .
To determine whether the R phenotype was permissive to T. cruzi infection, we incubated mutant and parental cells (Mv1Lu) with various concentrations of trypomastigotes at 37°C for 2 days to allow differentiation into, and replication of, intracellular amastigotes (Pereira, 1990) . Remarkably, R-1B cells were extremely resistant to T. cruzi infection in a wide range of parasite concentrations ( Figures 1A and 1C) . At the highest trypomastigote inoculure (2 x 106 parasites/monolayer), 43.1% _+ 10.7% of parental MvlLu cells were infected by T. cruzi compared with only 0.5% _ 0.1% for R-1B cells, representing >80-fold increase in resistance to infection in the R phenotype (Figures 1A and 1C) . Two types of DR mutant cells (DR-26 and DR-27) were tested for their potential to be infected by T. cruzi. The TGFI3 receptor II (TI3R-II) in DR-26 cells contains a single base mutation that transforms the seventh codon of the transmembrane region into a stop codon, and the TI3R-II in DR-27 contains a single base mutation that converts the third cysteine of the extracellular domain to tyrosine (Wrana et al., 1992) . The TI3R-I in both DR-26 and DR-27 contains no mutation (Wrana et al., 1992) . When these DR cell lines were tested for their potential to be infected by T. cruzi, they were found to be highly resistant to invasion ( Figure 1B ).
T. cruzi Attaches to, but Cannot Penetrate, Epithelial Cells Expressing Defective TI]R-I or TI~R-II
The resistance of R and DR mutants to being infected by T. cruzi could result from the inability of the parasites to attach to surface receptors, to enter the cells, orto differentiate and replicate intracellularly. To determine whether adherence was a mechanism of resistance, trypomastigotes were incubated with glutaraldehyde-fixed monolayers of parental and mutant cells. These cells should allow binding but not invasion of the parasites (OrtegaBarria and Pereira, 1991) . We found that T. cruzi attached to the mutant cells at levels similar to or higher than those supported by parental cells (Figure 2A) . Therefore, the inability of T. cruzi to infect the TI3R mutant cells was not at the level of adhesion receptors.
To determine whether the adherent parasites were capable of penetrating the mutant cells, parasites were incubated with live monolayers of MvlLu, R, and DR cells for 1 hr to allow attachment and entry. The monolayers were washed to remove unbound trypanosomes and fixed with glutaraldehyde, making the outer membrane impermeable to macromolecules. In this way, residual extracellular parasites could be quantitated with polyclonal antibodies against T. cruzi, and intracellular and extracellular parasites with DNA stains such as DAPI (Schenkman et al., 1991) . We found that trypomastigotes entered parental but not T~R mutant cells ( Figure 2B ). The inability of T. cruzi to grow in the R and DR mutants results, therefore, from a defect in penetration of the epithelial cells. Similar inability to penetrate was observed in the interaction of T. cruzi with TGF~-resistant colon (SW480) and bladder (EJ) carcinoma cell lines ( Figure 2B ; Geiser et al., 1992; see below) . A TGFI3-susceptible hybrid of the two cell lines (HYB-2) was more permissive to T. cruzi penetration than parental cells ( Figure 2B ). Moreover, T. cruzi did not efficiently enter a TGFl~-resistant H-ras-transformed rat cell line (IEC-ras7) ( Figure 2B ), whereas it invaded the TGFJ3-sensitive parental IEC-18 cells ( Figure 2B ; Filmus et al., 1992; see below) .
Restoration of Permissiveness to T. cruzi Infection by Transformation with TJ~R Genes
To assess the ability of signaling TI~Rs to mediate T. cruzi invasion, we stably transfected DR-27 cells with a human TI3R-II cDNA (Lin et al., 1992) . Remarkably, transfected DR-27 cells became permissive hosts for T. cruzi invasion at levels comparable to those of wild-type Mv1Lu (Table  1 ). This confirmed that the nonpermissiveness of DR-27 cells was due to a defect in their signaling pathway at the level of the TI3Rs. The transfectant clones expressed human TI3R-II on their surface because TGFI31 inhibited [aH] thymidine incorporation into DNA of the growing cells in response to TGFI3 ( Figure 3A ). To prove this point further, the transfectants were treated with radioiodinated TGFI31 and incubated with the chemical cross-linker disuccinimidyl suberate to label the TI3Rs (Massagu~, 1987 ). The labeled receptors were then resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and visualized by autoradiography. While the DR-27 mutant showed a concomitant loss of receptors I and II, the transfectant clones showed a normal receptor labeling pattern ( Figure  3B ) as in reported results (Wrana et al., 1992) .
Likewise, transfection of resistant R-1 B cells with TI3R-I gene (ALK-5) (Franzen et al., 1993) restored T. cruzi invasion to levels comparable to those of parental cells ( Figure  1C ). Transfected R-1B clones, such as R-1 B-TR25 shown in Figure 1C , were growth arrested by TGFI31 in a kinetics and dose response similar to that with parental MvlLu cells (M. M. and M. E. A. P., unpublished data). Cell lines were incubated with the indicated concentrations of T. cruzi for I hr and, after removing unbound parasites by washing, they were further incubated at 37 ° C for 3 days. Infection was quantitated by determining the percentage of cells containing more than two amastigotes. Results are representative of three others and represent an average of quadruplicate points.
MvlLu is the parental cell line of mutant DR-27, which lacks TI3R-II; DR27-47 is the DR-27 mutant transfected with a plasmid encoding TI3R-II (see Figure 3) . c Similar results were obtained with the transfectant DR27-TR50 (see text). 
Activation of Mammalian Cells with TGFpl Enhances Infection in a Specific Manner
The above results suggest that the TI3Rs are required for T. cruzi invasion. This opens the possibility that signaling through the receptors directs parasite invasion. As a first approach to investigate this possibility, we asked whether activation of the receptors facilitated T. cruzi invasion. For this, Mv1Lu cells were treated with TGFI31 (1.0 ng/ml) for 2, 8, and 24 hr, washed to remove residual cytokine, and assayed for their ability to be infected by T. cruzi. The results show that TGF~l-primed cells supported T. cruzi infection much more efficiently than nonsensitized cells ( Figure 4A ). Similar increase in infection was obtained by priming Mv1Lu cells with another isoform of TGF~, TGFJ32 (data not shown). The rise in infection resulting from the sensitization with TGF~ required signal transduction through the T~Rs because DR-27 cells did not become a better host after priming with TGFI~ ( Figure 4A ). Furthermore, clones of DR-27 transfected with TI3R-II behave like parental cells upon sensitization with TGF~I ( Figure 4A ). Sensitization with epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) did not affect T. cruzi invasion (data not shown). TGFI3-activated cells did not become more permissive to another intracellular protozoan parasite, Toxoplasma gondii ( Figure 4B ), which resides inside cytoplasmic vesicles of a variety of mammalian cells (Schwab et al., 1994) . Furthermore, T. gondii invaded DR-27 cells to the same extent as parental mink lung cells ( Figure 4B ). Thus, the , and stable transfectants DR27-TR47 and DR27-TR50 were grown in the absence (control) or in the presence of TGFp,1 (2 ng/ml) for the indicated times and infected with T. cruzi (1 x 10 s trypomastigotes/well for 2 hr, washed, and then further incubated for 2 days at 37°C).
(B) Parental and DR-27 cells without priming (control) or primed with TGFI31 (1 ng/ml, 24 hr) were infected with T. gondii for 2 days. (C) MvlLu cells were grown for 24 hr in the absence (control) or in the presence of the indicated concentrations of TGF~I, rapamycin, and a cAMP analog (Bt2cAMP), and then infected with T. cruzi for 2 days as in (A). Cell cycle distribution of subeonfluent Mvl Lu cells treated with rapamycin (40 ng/ml for 21 hr) was as follows: G1 = 93.0%, S = 6.3%, and G2/M = 0.7%, compared with G1 = 48.8%, S = 16.9%, and G2/M = 34.3% for the control cells not treated with rapamycin.
increase in invasion by activation with TGFI3 may be specific for T. cruzi. MvlLu cells treated with TGFI31 under the conditions described in Figure 4 are arrested at mid-to late-G1 phase of the cell cycle (Massagu6, 1990) . To determine whether the increased susceptibility to T. cruzi infection was a direct consequence of the G1 arrest, regardless of the cellular stimulus, we treated MvlLu cells with cyclic AMP (cAMP) or rapamycin for 24 hr prior to using them as host for T. cruzi. Under these conditions, cAMP arrests cell growth at G1 and G2 (Boynton and Whitfield, 1983;  M. E. E., unpublished data) and rapamycin only at G 1 (see legend to Figure 4C ). Treatment of MvlLu cells with a cAMP analog or with rapamycin did not significantly increase T. cruzi invasion, compared with the sharp rise induced by TGFI31 sensitization ( Figure 4C ). Because priming with rapamycin, which arrests the cell cycle at G1, and with the growth factors EGF and PDGF, which stimulate cell multiplication, did not enhance invasion of T. cruzi, the enhancement in TGFI3-activated Mvl Lu cells appeared to be specific for the antiproliferative cytokine.
Moreover, TGFI31 priming of monkey fibroblasts (Vero cells) and bovine endothelial cells enhanced T. cruzi infection significantly, and the enhancement was blocked by TGFl~-neutralizing antibodies (M. M. and M. E. A. P., unpublished data), suggesting that T. cruzi may use the TGFI3 signaling pathway to invade a variety of cell types. However, TGFl3-activated human or mouse macrophages did not become better hosts for T. cruzi (M. M. and M. E. A. P., unpublished data), suggesting that the TGFI3 signaling pathway may not be critical for T. cruzi invasion of phagocytic cells.
Restoration of T. cruzi Invasion in a Hybrid of Two Nonresponsive Human Carcinoma Cell Lines
Further evidence that efficient T. cruzi invasion of host cells requires TGFI3 signaling was provided by the response of a hybrid of two TGFl3-resistant human carcinoma cell lines. Previous studies showed that this hybrid cell line expresses much higher levels of surface TISR-II than parental EJ bladder carcinoma and the SW480 colon adenocarcinorna cells (Geiser et al., 1992) . Consequently, the cell hybrid, but not the parental cell lines, is growth arrested in response to TGFI~ ( Figure 5A ) (Geiser et al., 1992) . When these cell lines were tested for permissiveness to T. cruzi invasion, the difference in host potential between the TGFI3-resistant carcinoma cells and a TGF~-sensitive hybrid (HYB-2) cell line was very dramatic indeed (Figures 2B, 5B, and 5C). As already discussed above, trypomastigotes penetrated TGFl~-resistant parental carcinoma cells inefficiently compared with their invasion of the TG Fl~-sensitive hybrid ( Figure 2B ). Moreover, T. cruzi infected poorly (less than 10%) parental carcinoma cells and robustly (nearly 80%) HYB-2 cells (Figures 5B and 5C) . Furthermore, T. cruzi infected nearly all TGFI3-activated HYB-2 cells and only about 10% of TGFIBactivated parental carcinoma cells ( Figure 5B ). These findings further underscore the critical role of TGFI3 signaling in promoting T. cruzi invasion of mammalian cells.
Constitutive Expression of the Cyclin-Dependent Kinase Cdk4 or Transformation with the Oncogene H-ras Renders Epithelial Cells Resistant to Both TGFp Activation and T. cruzi Invasion
Normal progression through the G1 phase of the cell cycle is promoted by the activity of the cyclin-dependent protein kinases cdk2 and cdk4 (Sherr, 1993) . In mink lung cells, TGFI~ inhibits cellular proliferation largely by down-regu- These experiments were repeated more than four times with similar results• lating the activity of cdk2 and cdk4 kinases (Ewen et al., 1993; Koff et al., 1993) . TGFI3 inactivates cdk4 directly by decreasing the level of cdk4 expression, and constitutive expression of cdk4 turns Mvl Lu cells resistant to the effects of TGFI31 (Ewen et al., 1993) . We tested the permissiveness to T. cruzi invasion of the MvlLu-derived cdk4 clone (B7), which expresses cdk4 constitutively at relatively high levels (Ewen et al., 1993) . Remarkably, this Mvl Lu-cdk4 clone was not only resistant to T. cruzi invasion, but their low permissiveness was not significantly enhanced by TGFI32 priming, contrary to the steep rise in T. cruzi invasion of TGFI3-sensitized parental cells (Figure 6A ). Another type of intracellular dysfunction that confers resistance to TGFI3 results from overexpression of the activated human oncogene H-ras (Filmus et al., 1992) . As already discussed, the rat intestinal cell IEC-18 is growth arrested by TGFI3, but after transformation with H-ras, it may become insensitive to the growth factor (Filmus et al., 1992) . We found that parental, TGFI3-sensitive IEC-18 cells were invaded by T. cruzi in a TGFl~-enhanceable manner, whereas an H-ras-transformed, TGFI3-resistant derivative of IEC-18 cells (IEC-ras7 clone) was not ( Figure  6B ). Resistance to infection was due to a defect in T. cruzi penetration of TGFI3-resistant IEC-ras7 ( Figure 2B ). Thus, because cdk4 clone and IEC-ras7 cells express normal TGFI3 surface receptors (Ewen et al., 1993; Filmus et al., 1992) , the results with the cdk4 and H-ras clones indicate that T. cruzi invasion of epithelial cells requires intact TGFI3 signaling pathway and not just the availability of functional TI3Rs.
Invasive, but Not Noninvasive, T. cruzi and Parasite Conditioned Medium Activate a TGFl~-Responsive Reporter Gene
The above results suggest that downstream signaling proteins are important for T. cruzi invasion. To test the possibility that T. cruzi directly activates signal transduction through the TI3Rs, we incubated live parasites with monolayers of Mv1 Lu cells stably transfected with a plasminogen activator inhibitor-1 (PAl-l) construct (Abe et al., 1994) . The construct is a plasmid containing a truncated PAl-1 promoter fused to the firefly luciferase reporter gene.
Transfected cells increase luciferase activity to a great extent after stimulation with TG FI~, but minimallywith other inducers of PAl-1 expression and growth factors (Abe et al., 1994) . We found that invasive trypomastigotes induced luciferase activity in transfected MvlLu cells in a dosedependent manner, whereas noninvasive epimastigotes had no effect ( Figure 7A ). PAl-1 promoter activation by live trypomastigotes was also de monstrated in cells transiently transfected with another PAl-1 promoter-luciferase construct, p3TP-Lux (Wrana et al., 1992 ; data not shown). We then determined whether proteins shed by T. cruzi would contain the PAl-1 promoter activator. For this, we prepared an extract of live parasites by incubating them Luciferase activity was determined in cell monolayers that had been incubated for 20 hr in the absence (control) and in the presence of the indicated concentrations of TGF~I and trypomastigote extract (Trypo extract) and epimastigote extract (Epi extract).
(C) Lack of PAl-1 promoter activation by trans-sialidase and penetrin. Mvl Lu cells transiently transfected with p3TP-Lux were grown in the absence (control) and in the presence of the indicated concentrations of trypomastigote extract (Tryp, in pg/ml), purified trans-sialidase (TS, in ng/ml), penetrin (PN, in p.g/ml), and TGFI~I (in ng/ml). Note that TS and PN did not induce PAl-1 response while the induction of the PAl-1 promoter by the trypomastigote extract in this experiment was even greater than that in the experiment shown in (B).
at 4°C for 2 days in RPMI medium containing a cocktail of protease inhibitors followed by centrifugation and filtration through 0.22 I~m pores. This cell-free RPMI extract contains mostly surface and secreted proteins (Cavallesco and Pereira, 1988) . Remarkably, extract from invasive trypomastigotes, but not from noninvasive epimastigotes (4 and 8 i~g/ml), induced luciferase activity to a great extent ( Figure 7B ). Unequivocal demonstration that T. cruzi activates the TIeR signaling pathway was provided with DR and R mutant cells transiently transfected with p3TP-Lux. Neither TG FI31 nor the trypomastigote extract activated the PAl-1 promoter in DR-27 and R-1B cells ( Figure 7B ). However, when DR-27 cells and R-1 B cells were transiently cotransfected with p3TP-Lux and with plasmids containing T~R-II or TI~R-I genes, respectively, they produced high luciferase activity upon stimulation with either TGFI[}I or trypomastigote extract, but not with epimastigote extract (Figure 7B) . Cotransfection of DR-27 mutants with p3TP-Lux plus empty pcDNA I ( Figure 7B , DR27-vector) or with a plasmid containing a kinase-deficient receptor II construct (Chen and Weinberg, 1995;  Figure 7B , DR27-K277R) did not produce promoter response to TGFI31 nor to T. cruzi. Like TGFI3, which inhibits DNA synthesis and cell proliferation in many cell types (Massagu~, 1990) , trypomastigote extract inhibited DNA synthesis ([3H]thymidine incorporation) in TGFI3-responsive Mv1Lu cells but not in TGFI3-resistant DR-27 and R-1B cells (data not shown). Noninvasive epimastigotes did not inhibit DNA synthesis in Mvl Lu cells. These results further confirm the stimulation of the TGFI3 signaling pathway by T. cruzi. This stimulation was selective for T. cruzi because a similar extract from two other protozoan parasites, Plasmodium falciparum (-108 trophozoites plus schizont stages/ml) and T. gondii (-108 tissue culture forms/ml), did not activate the PAl-1 promoter (M. M. and M. E. A. P., unpublished data).
Trans-sialidase and penetrin are surface proteins implicated in parasite adhesion to mammalian cells (Pereira, 1994) . Because these proteins are present in the trypomastigote extract, it is possible that they will bind to cell surface sialyl and heparan sulfate epitopes and activate the TGFI3 signaling pathway. However, purified transsialidase, at concentrations similar to those in the trypomastigote extract, did not trigger PAl-1 promoter response in transiently transfected Mv1 Lu cells ( Figure 7C ), nor did purified penetrin at relatively high concentrations (Figure 7C) .
We have partially purified the TGFl~-Iike factor from trypomastigote extracts through several steps of conventional protein fractionation procedures. The factor did not react with a variety of commercial TGFI3 monoclonal and polyclonal antibodies, as determined by neutralization of biological activity, immunoblot, and ELISA (M. M. and M. E. A. P., unpublished data).
Discussion
TGFI3 is a cytokine that alters many functions in nearly all higher eukaryotic cells (Roberts and Sporn, 1990) . The nature of the TGFI3 action depends on many parameters, including type and state of differentiation of the cell targets, growth conditions, and presence of other growth factors. TGFI3 controls extracellular matrix production, regulation of myogenesis, immune response, angiogenesis, and embryogenesis. Here, we report that utilization of the TGFI3 signaling pathway by a pathogenic microbe is essential for the invader to gain access and thrive in the cytosol of nonphagocytic host cells.
Many types of evidence support the hypothesis that T. cruzi invasion requires activation of the TGFI3 signaling pathway. T. cruzi could not infect, or infected extremely inefficiently, m ink lung epithelial cells with a genetic defect in TI3R-I or TI3R-II ( Figures 1A and 1B) . Reconstitution of TI3R function by transfection with human receptor I or II restored sensitivity of the mutants to TGFI3 and permissiveness to T. cruzi invasion ( Figure 1C ; Table 1 ). Similarly, T. cruzi did not efficiently invade the human EJ bladder carcinoma cell line nor the human SW480 colon adenocarcinoma cells ( Figure 5B ). These cells express relatively low levels of TI3R-II and thus are resistant to TGFI3-induced growth arrest ( Figure 5A ; Geiser et al., 1992) . However, fusion of EJ cells with SW480 cells produced a hybrid cell sensitive to TGFI3 due to high level expression of receptor II ( Figure 5A ; Geiser et al., 1992) . Rescue of TGFI3 response in the hybrid cell line correlated with a remarkable permissiveness to T. cruzi invasion (Figure 5B) . Another approach to demonstrate the importance of the TGFI3 signaling for T. cruzi invasion was to infect cells genetically engineered to constitutively overexpress cdk4 kinase and H-ras oncogene, which make them growth resistant to TGFI3 (Ewen et al., 1993; Filmus et al., i992) . Consistent with the other results summarized above, mink and rat epithelial cells with deregulated cdk4 and H-ras expression were very poor hosts for T. cruzi ( Figures 6A and 6B ).
The conclusion from these genetic studies was consistent with the enhanced T. cruzi invasion of TGFl~-sensitized wild-type cells from different animal species and of various lineages ( Figure 4A ; unpublished data). Enhancement of invasion was specific for TGFI~, since priming of the cells with other growth factors (EGF and PDGF) and with molecules capable of eliciting a G1 growth arrest (rapamycin and cAMP) did not increase invasion.
Our findings are consistent with early studies demonstrating a dependency of T. cruzi invasion on the phase of the host cell cycle. Specifically, T. cruzi invasion of synchronized cultured cells increased as the cells progressed from G1 to the S phase of the cell cycle and dropped sharply as the cells entered G2/M (Dvorak and Crane, 1981) . According ly, Mvl Lu and other cells arrested at midto late-G1 by TGFI3 (Massagu6, 1990) were much better hosts for T. cruzi than asynchronous culture cells ( Figure  4 ). However, cell arrest at G1 per se did not necessarily lead to enhanced trypanosome invasion, as suggested by the results with rapamycin, which blocks cells such as Mvl Lu at G1 (see legend to Figure 4C ), through a mechanism distinct from the TGFI3 arrest (Kato et al., 1994) . In addition, cells growth arrested at GO/G1 by contact inhibition are much poorer hosts for T. cruzi than subconfluent cells progressing through the cell cycle (Henriquez et al., 1981; Dvorak and Crane, 1981) . Thus, contrary to the TGFI3 arrest, contact inhibition and rapamycin-induced G1 block did not turn the cells into better hosts for T. cruzi, underscoring the specificity of the TGFI3 signaling pathway in directing trypanosome invasion.
Our results also provide a logical explanation for early observations about the effect of T. cruzi and TGFI3 on skeletal muscle differentiation. Thus, T. cruzi infection of L6E9 rat myoblasts prevented the myoblasts from fusing into multinucleated myotubes (Rowin et al., 1983) , an effect similar to that of pu rifled TG FI3 (Massagu6 et al., 1986) . Furthermore, T. cruzi reduced the expression of musclespecific mRNA (Rowin et al., 1983) , as did TGFI3 (Massague et al, 1986) . Moreover, the L6E9 cells, once committed to myogenic differentiation, became resistant to the inhibitory effect of both T. cruzi and TGFI~, even though the differentiated cells were still able to be infected by T. cruzi and to be bound by TGFI~ (Rowin et al., 1983; Massagu6 et al., 1986) . Thus, in view of the parallel actions of T. cruzi and TGFI3 on skeletal muscle differentiation in vitro, we hypothesize that the parasite-induced inhibition of myogenic differentiation results from trypomastigote activation of TIeRs.
If T. cruzi invasion requires activation of the TGFI3 signaling pathway, then what turns the pathway on, the host TGFI3, the parasite-specified TGFI3-1ike factor, or both? Previous studies suggest that spleen cells from mice with acute T. cruzi infections produced elevated levels of TGFI3 in vitro (Silva et al., 1991) . This elevation could result from T. cruzi activating host-derived TGFI~ precursor into the active 25 kDa peptide. Other studies showed that proteases and sialidases can process the TGFI3 precursor into the active peptide (Miyazono and Heldin, 1989) . Interestingly, T. cruzi secretes both protease (Cazzulo et al., 1989) and sialidase (Pereira, 1983) proteins. Therefore, the intriguing possibility that T. cruzi can correctly process host TGFI3 precursor molecules should be further investigated.
On the other hand, we found that T. cruzi itself, specifically its invasive trypomastigote form, activates a TGFI3-responsive extracellular matrix protein (PAl-l) promoter of transfected Mvl Lu epithelial cells (Figure 7 ; Abe et al., 1994) . Trypomastigotes release a factor that engages the TGFI3 signaling receptors, as judged by the activation of another PAl-1 promoter construct (p3TP-Lux) in MvlLu cells (Wrana et al., 1992) by soluble proteins shed by invasive trypomastigotes. This T. cruzi-derived TGFI3-1ike factor is distinct from host TGFI3 by many criteria, including physical properties like resistance to boiling (30 min at 100°C; M. M. and M. E. A. P., unpublished data). Thus, it may also be that T. cruzi invasion is directed by a parasite-specified product that activates the TGFI~ signaling pathway.
It is becoming evident that intracellular microbes can bind to cell surface receptor signaling proteins during their interaction with host cells. The bovine papilloma virus protein E5 dimerizes in the plasma membrane, activates receptors for several growth factors (Petti and DiMaio, 1992) , and binds to a vacuolar H+-ATPase to affect receptor recycling (Goldstein et al., 1991) . The Epstein-Barr virus transforming protein LMP1 engages signaling proteins coupled to the tumor necrosis factor receptor family (Mosialos et al., 1995) , and the HIV virus binds to CD4 receptors on lymphocytes as a requirement to invasion (Olshevsky et al., 1990) . These and other interactions (Gooding, 1992 ) may be important not only in facilitating parasite growth but also in allowing the virally infected cells to evade cellular host defense mechanisms. Identification of relevant parasite ligands and characterization of the cellular changes induced by ligand-host cell interactions is an exciting and flourishing area of current microbiological research (Bliska et al., 1993) .
On the basis of the results presented here and elsewhere (Pereira, 1994) , we propose that T. cruzi invasion starts with trypomastigotes attaching to host cells through at least two pathways involving trans-sialidase/sialic acid and penetrinlheparan sulfate recognition. These proteincarbohydrate interactions do not induce cellular invasion, which, at least in cells growth arrested by TGFI3, is driven by the activation of the TGFI3 signaling pathway through ligands distinct from trans-sialidase and penetrin. TGFI3 signaling may be turned on either by host TGF~, by a TGFI3-1ike peptide released into the environment by the invading trypomastigotes, or by both. It will be of great interest to determine the mechanism used by T. cruzi to trigger TGFI~ signaling, whether that is the pathway that leads to G1 arrest, the pathway that induces extracellular matrix deposition, or both. It is likely that activation of the antiproliferative pathway is a requirement for invasion, as judged by the correlation between TGF~-induced inhibition of DNA synthesis in various mammalian cell types and T. cruzi invasion. On the other hand, T. cruzi and T. cruzi extracts strongly activate a promoter for an extracellular matrix protein (Figure 7) , suggesting that this pathway may be activated as well. Ascertaining these problems are not just of academic interest, for a T. cruzi-specified activation of the TGFI3 pathway might underlie responses such as immunosuppression (Wahl et al., 1988) and abnormal extracellular matrix deposition (Border and Ruoslahti, 1992) , each a dominant feature in humans and experimental animals with acute (Brener and Krettli, 1990 ) and chronic Chagas' disease (Koberle, 1968; Andrade, 1983) , respectively.
Experimental Procedures Parasites
The Silvio X-10/4 and Tulahuen clones of T. cruzi were obtained by infection of cultured Vero cells as previously described (Cavallesco and Pereira, 1988) . The T. cruzi cell-free RPMI extract was obtained by incubating trypomastigotes and epimastigotes (from LIT medium) (2 x 10S/ml)for2 daysat4°CinRPMIcontainingacocktailofprotease inhibitors (10 p_M pepstatin A, 10 p.M leupeptin, 10 mU/ml aprotinin, 5 mM EDTA, and 10 mM iodoacetamide), centrifuging the suspension (1000 x g, 10 min), and filtering the supernatant through 0.22 ~m pores. A RPMI extract of human red blood cells infected with P. falcipa[um (containing a mixture of schizonts and trophozoites at -10el ml) was obtained in a manner similar to that of T. cruzi (gift from Drs. G. Pasvol and B. Clough).
Cell Lines and Cell Culture
The MvlLu mink lung cell line was from the ATCC (CCL-64), and the Mv1Lu-derived T~R mutants DR-26, DR-27, and R-1B were provided by Dr. J. Massagu~ (Laiho et al., 1990; Wrana et al., 1992) . The SW480 colon adenocarcinoma cell line was from ATCC (through Dr. J. Sharon), and the EJ bladder carcinoma cell line and the hybrid (HYB-2) of SW480 with EJ cells were provided by Dr. A. Geiser (Geiser et al., 1992) . The rat intestinal cell line IEC-18 and an IEC-18 clone transformed with human H-ras oncogene (IEC-ras7) were provided by Dr. J. Filmus (Filmus et al., 1992) . The cdk4 B7 clone was the cell line used in previous studies (Ewen et al., 1993) . Cell lines were maintained as described in the references cited above.
Infection Assay
Infection of culture cells was carried out as described previously (Cavallesco and Pereira, 1988) . Subconfluent monolayers were incubated for 1-2 hr at 37°C with various concentrations of trypomastigotes in 0.1 ml of RPMI-BSA, washed with RPMI to remove swimming parasites, and further incubated for 2-3 days at 37°C in RPMI-1640 containing 5% FCS. Diff-Quik-stained preparations were examined under a microscope to estimate the ratio of infected (i.e., cells containing more than one intracellular amastigote) to noninfected cells.
A similar protocol was used to infect monolayers with T. gondii, RH strain, provided by Dr. K. Joiner (Schwab et al., 1994) .
Adhesion Assay
Adhesion of trypomastigotes to monolayers of glutaraldehyde-fixed cells was performed as previously described (Ortega-Barria and Pereira, 1991; Ming et al., 1993) . In brief, trypomastigotes (lO~lwelllO.1 ml of RPMI-BSA) were incubated at 37°C with glutaraldehyde-fixed monolayers in 16-well Lab-Tek chamber slides. After 1 hr, swimming and loosely bound parasites were removed by dipping the slides 10 times in PBS. Adherent parasites were fixed for 10 rain with 4% paraformaldehyde in PBS containing 7% sucrose. After rinsing with PBS, the slides were stained with Diff-Quik and examined under a light microscope to assess T. cruzi adherence. A minimum of 300 host cells were counted for each point.
Penetration Assay
Monolayers of the various cell types, equilibrated in RPMI-BSA medium, were incubated with trypomastigotes (6 x 106/ml) for 1 hr at 37°C, washed in cold HEPES-buffered (pH 7.2) RPMI, fixed in 2o/0 paraformaldehyde in 100 mM lysine for 20 min, and blocked with 50 mM ethanolamine (Schenkman et al., 1991) . The monolayers were fixed one more time in 1% glutaraldehyde for 1 hr at room temperature and blocked with 1% BSA overnight at 4°C. The monolayers were then reacted for 30 min with IgG (20 p.g/ml) purified from human Chagasic sera (Cavallesco and Pereira, 1988) and washed several times with PBS, and the bound IgG were detected with an FITC-labeled second antibody (Sigma). After washing with PBS, the DNA of the host cells and the parasites was stained with DAPI (Sigma) at 5 p.g/ ml and observed under a Nikon epifluorescence microscope.
Receptor Affinity-Labeling Assay
These assays were performed precisely as described by Massagu~ (1987) , except that [1251]TGFI31 (specific activity 137 tLCi/p~g) was from a commercial supplier (Dupont-New England Nuclear).
Growth Inhibition Assay
Cells were seeded in 96-well flat-bottomed plates, grown overnight at 37°C in 10% FCS in RPMI, and incubated with various concentrations of recombinant human TGF~t (R & D Systems) or TGFI32 (Genzyme), EGF or PDGF (R & D Systems), BtcAMP (Sigma), rapamycin, or T. cruzi RPMI extract. After 2 days, cells were labeled with 1 ~Ci/ml [3H]thymidine (specific activity 16.8 Ci/mmol; Dupont-New England Nuclear) for 18 hr, washed three times with cold PBS, extracted with 0.2 N NaOH for 30 rain, and counted in a scintillation counter. Each assay was carried out in triplicate or quadruplicate.
Transfection A~says DR-27 and R-1B cells stably expressing human T~R-II tagged with FLAG epitope in pRK5 (Chen et al., 1993 ) (gift of Dr. R. Derynck) or TI~R-I (ALK-5) in pSV7d (Franzen et al., 1993) (gift from Drs. C.-H. Heldin and K. Miyazono), respectively, were generated by transfection with lipofectin as recommended by the manufacturer (GIBCO-BRL). In brief, cells growing in 60 mm dishes were incubated overnight in serum-free medium containing 2 p.g of DNA and 10 I~g of lipofectin and then washed into media containing 10% FCS and antibiotics. After 2 days, cells were subcultured into several 75 cm 2 flasks and grown in the presence of 25 ~g/ml mycophenolic acid (GIBCO-BRL) for 2-3 weeks with a change in media every 4-5 days. Mycophenolic acidresistant cells were cloned in microtiter wells by limited dilution in the presence of 10% FCS. After 2-3 weeks, each colony was tested for sensitivity to the antiproliferative action of TGFJ31, and those growth arrested by the cytokine were incubated with [1251]TGFI31 and ascertained for the prese rice of TI3Rs with the chemical cross-lin ker disuccinimidyl suberate. Transfectants sensitive to TGF~ were continuously maintained in hygromycin. In this way, we generated two clones of DR-27 cells expressing human TI3R-II (DR27-47 and DR27-50) and six clones of R-1B expressing ALK-5 (R1B-TR9, RIB-TR11, RIB-TR16, RIB-TR20, RIB-TR22, and RIB-TR25).
Transient Transfections and Luciferase Assays
Parental cells were plated to semiconfluency in 6-well tissue culture plates, and 24 hr later transfected with lipofectin in serum-free medium using 2.0 p.g of reporter plasmid (p3TP-Lux) (gift of Dr. J. Massagu~, see Wrana et al., 1992) . For DR and R cells, they were transfected with 2.0 ~g of p3TP-Lux without and with 0.5 p.g of T~R-II in pcDNA-1 vector (Lin et al., 1992) or kinase-deficient T~R-II (Chen and Weinberg, 1995) (gifts from Dr. R. Weinberg) or ALK-5 in pSV7d vector (Franz~n et al., 1993) , respectively. After overnight incubation at 37°C in a 5% COz atmosphere, the medium was replaced with 10% FCS in RPMI and incubated for a further 48 hr at 37°C, followed by TGF~, T. cruzi, or RPMI extract of T. cruzi and P. falciparum. After 20 hr, cells were harvested and assayed for luciferase activity using the luciferase assay system described by the manufacturer (Promega). Light emission was measured during the initial 30 s of the reaction using a luminometer (MONOLIGHT 2010, Analytical Luminescence Laboratory) (courtesy of Drs. A. Leiter and A. Kopin).
For introduction of reporter construct in transfected DR-27 and R-1B clones (see above), a procedure similar to the one described above was followed, except that the TI3R constructs were ommitted.
Determination of reporter activity in Mv1Lu cells stably transfected with PAl-1 promoter construct (gift from Dr. D. Rifkin) was as described by Abe et al. (1994) .
Other Procedures
Penetrin and trans-sialidase were isolated from T. cruzi by heparin affinity chromatography (Herrera et al., 1994 ) and a combination of immunoaffinity and sieving chromatography (Scudder et al., 1993) , respectively. Cell cycle determination was determined as previously described (Ewen et al., 1993) .
